The Week In... Medical Devices (20-24/01)
  • Posted on: 24/01/2020
  • Category: Industry

The Week In... Medical Devices (20-24/01)

The designer of a Parkinson’s diagnosis pen signs a five-year manufacture deal, Scottish Enterprise grants medtech firm EnMovi £2.5m, the NHS Digital toolkit now allows logins for approved digital health and care app developers, and a post-Brexit trade panel is to feature at next week's Arab Health.

Interested in Star’s innovative outsourcing and resourcing solutions?

Contact Operations Director, Mark Ward, on 07872 105 540 or email mark.ward@starmedical.co.uk.

On the hunt for a new role, or just curious?

Visit our candidate page, submit your CV to candidates@starmedical.co.uk, or give our offices a ring!

Scottish Enterprise grants medtech firm £2.5m R&D grant

Medtech firm EnMovi has selected Glasgow as the location to advance its development of orthopaedic sensors and data analytics after receiving a £2.5 million R&D grant from Scottish Enterprise.

Parkinson’s diagnosis pen pioneer signs five-year manufacture deal

The Edinburgh firm behind a digital pen which helps diagnose and treat people with neuromotor medical conditions has signed a five-year deal with stationery brand Stabilo.

Post-Brexit trade panel to feature at Arab Health

Links with global markets, including the Middle East, will be part of the focus of this year’s Arab Health as the UK prepares to leave the European Union.

Holding breath could improve radiotherapy for cardiac arrhythmias

Patients holding their breath for five minutes or more could be used to support an emerging new radiotherapy technique for cardiac ablation, according to researchers at the University of Birmingham.

NHS Digital toolkit launched to integrate health and care apps

Approved digital health and care app and website developers can now integrate NHS login into their products thanks to a new toolkit launched by NHS Digital.

While you’re here…

…and are interested in our content, why not sign up to our newsletter? It’s just below here.